We are live on
!
Find out more
Ginkgo Bioworks
DNA
DNA
313 hedge funds and large institutions have $1.51B invested in Ginkgo Bioworks in 2023 Q1 according to their latest regulatory filings, with 44 funds opening new positions, 102 increasing their positions, 81 reducing their positions, and 47 closing their positions.
New
Increased
Maintained
Reduced
Closed
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
26% more repeat investments, than reductions
Existing positions increased: 102 | Existing positions reduced: 81
9% more call options, than puts
Call options by funds: $4.29M | Put options by funds: $3.93M
0.05% less ownership
Funds ownership: 1.86% → 1.81% (-0.05%)
6% less first-time investments, than exits
New positions opened: 44 | Existing positions closed: 47
2% less funds holding
Funds holding: 320 → 313 (-7)
10% less capital invested
Capital invested by funds: $1.68B → $1.51B (-$166M)
Holders
313
Holders Change
-7
Holders Change %
-2.19%
% of All Funds
4.99%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
44
Increased
102
Reduced
81
Closed
47
Calls
$4.29M
Puts
$3.93M
Net Calls
+$355K
Net Calls Change
-$4.25M
Top Buyers
| 1 |
Viking Global Investors
Stamford,
Connecticut
|
+$127M |
| 2 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$32.3M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$14.8M |
| 4 |
Morgan Stanley
New York
|
+$12.6M |
| 5 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$10.7M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$6.96M |
| 2 |
Two Sigma Investments
New York
|
-$2.96M |
| 3 |
Norges Bank
Oslo,
Norway
|
-$2.41M |
| 4 |
Baillie Gifford & Co
Edinburgh,
United Kingdom
|
-$2.07M |
| 5 |
Goldman Sachs
New York
|
-$2M |
